Empaone-M Tablet ER

Empaone-M Tablet ER is an extended-release oral diabetes medicine that combines empagliflozin and metformin in one tablet. Each strip/box contains Empaone-M Tablet ER tablets from MSN Laboratories, labeled to provide the fixed-strength empagliflozin plus metformin dose for this product. It belongs to the SGLT2 inhibitor and biguanide drug classes and is used to help lower blood sugar in adults with type 2 diabetes, along with diet and exercise.

How it works: Empagliflozin helps the kidneys remove extra sugar through the urine, which lowers blood glucose. Metformin reduces how much sugar the liver makes and helps the body use insulin better; in the tablet form, the extended-release design releases metformin more slowly to help steady coverage through the day.

Empaone-M Tablet ER is the extended-release tablet form, so it is designed to release medicine more gradually than immediate-release options like Empaone-M IR 12.5/500 Tablet. Because this exact strength is the as-labeled higher-dose ER option, a clinician may choose it for patients who need stronger glucose control and who have already been assessed for tolerability to metformin and empagliflozin.

• Type 2 diabetes mellitus
• Blood sugar control with diet and exercise
• Combination therapy when one medicine is not enough
• May help reduce the risk of diabetes-related complications when prescribed appropriately

• Swallow the Empaone-M Tablet ER whole with water; do not crush, split, or chew it.
• Take it at the same time each day, usually with a meal to help reduce stomach upset.
• If your prescriber says to take it once daily, take only one tablet in 24 hours.
• If your doctor prescribes it twice daily, follow that exact schedule and do not double up on your own.
• Stay hydrated, especially if you have vomiting, diarrhea, fever, or heavy sweating while taking this tablet.
• Check your blood sugar as directed, since this higher-strength ER tablet may lower glucose more noticeably than lower strengths in some patients.

Empaone-M Tablet ER is an as-labeled fixed-dose tablet of empagliflozin plus metformin in extended-release form, and the exact amount per tablet is determined by this product strength. It may be taken once daily or, if your doctor specifically prescribes it, in divided dosing; the maximum daily dose depends on your kidney function, other medicines, and how well you tolerate the tablet, so your doctor must decide the schedule and total daily amount.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Empagliflozin + Metformin may include:

• Diarrhea
• Nausea
• Stomach upset
• Gas or bloating
• Headache
• Increased urination
• Genital yeast infection or vaginal itching

• This tablet is for type 2 diabetes and is not used to treat type 1 diabetes or diabetic ketoacidosis.
• Because it contains metformin, kidney function must be checked before and during treatment.
• Alcohol can raise the risk of lactic acidosis, especially with higher metformin exposure.
• Empagliflozin can cause dehydration and low blood pressure, so use caution if you are older, on diuretics, or prone to dizziness.
• Tell your prescriber before surgery or major procedures, since this medicine may need to be held temporarily.
• Use caution if you have heart failure, liver disease, recurrent yeast infections, or a history of urinary tract infections.
• Do not use it to compensate for missed meals, and drive carefully if you feel dizzy or lightheaded.

• Insulin and sulfonylureas may increase the risk of low blood sugar.
• Diuretics can increase dehydration and low blood pressure.
• Alcohol increases the risk of metformin-related lactic acidosis.
• Iodinated contrast dye may require the medicine to be held around imaging studies.
• Certain blood pressure medicines may add to dizziness or kidney stress when combined with this tablet.

Store Empaone-M Tablet ER at room temperature in its original strip/box, away from moisture and excess heat.